Founded in 2020, Jamila Therapeutics AG is a privately owned global pharmaceutical company that aims to provide continued access to mature life changing therapies to patients around the world.

​

We are always interested in speaking with potential partners and private investors. Please look over our Company Presentation to learn more about who we are. While continuing to provide access to first world nations, we plan to invest further in emerging markets and low to middle income countries, which have rapidly growing middle classes, fast-growing and aging populations, rising chronic disease and a strong demand for recognized, quality medicines.